Advertisement
UK markets close in 1 hour 7 minutes
  • FTSE 100

    7,866.33
    -10.72 (-0.14%)
     
  • FTSE 250

    19,351.14
    -99.53 (-0.51%)
     
  • AIM

    744.03
    -1.26 (-0.17%)
     
  • GBP/EUR

    1.1672
    -0.0011 (-0.09%)
     
  • GBP/USD

    1.2451
    +0.0012 (+0.10%)
     
  • Bitcoin GBP

    51,864.80
    +783.16 (+1.53%)
     
  • CMC Crypto 200

    1,381.31
    +68.69 (+5.53%)
     
  • S&P 500

    4,999.36
    -11.76 (-0.23%)
     
  • DOW

    37,926.45
    +151.07 (+0.40%)
     
  • CRUDE OIL

    82.90
    +0.17 (+0.21%)
     
  • GOLD FUTURES

    2,399.50
    +1.50 (+0.06%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,764.22
    -73.18 (-0.41%)
     
  • CAC 40

    8,039.48
    +16.22 (+0.20%)
     

Do Institutions Own Surgalign Holdings, Inc. (NASDAQ:SRGA) Shares?

If you want to know who really controls Surgalign Holdings, Inc. (NASDAQ:SRGA), then you'll have to look at the makeup of its share registry. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. I quite like to see at least a little bit of insider ownership. As Charlie Munger said 'Show me the incentive and I will show you the outcome.

Surgalign Holdings is a smaller company with a market capitalization of US$101m, so it may still be flying under the radar of many institutional investors. Taking a look at our data on the ownership groups (below), it seems that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about Surgalign Holdings.

View our latest analysis for Surgalign Holdings

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Surgalign Holdings?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

ADVERTISEMENT

As you can see, institutional investors have a fair amount of stake in Surgalign Holdings. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Surgalign Holdings, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
earnings-and-revenue-growth

We note that hedge funds don't have a meaningful investment in Surgalign Holdings. Krensavage Asset Management is currently the company's largest shareholder with 4.3% of shares outstanding. In comparison, the second and third largest shareholders hold about 4.3% and 3.9% of the stock. In addition, we found that Terry Rich, the CEO has 1.5% of the shares allocated to their name.

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Surgalign Holdings

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our most recent data indicates that insiders own some shares in Surgalign Holdings, Inc.. It has a market capitalization of just US$101m, and insiders have US$8.5m worth of shares, in their own names. It is good to see some investment by insiders, but we usually like to see higher insider holdings. It might be worth checking if those insiders have been buying.

General Public Ownership

The general public, who are usually individual investors, hold a 48% stake in Surgalign Holdings. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Company Ownership

We can see that Private Companies own 4.3%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with Surgalign Holdings (including 1 which shouldn't be ignored) .

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.